CDKN1C anticorps (N-Term)
Aperçu rapide pour CDKN1C anticorps (N-Term) (ABIN7188927)
Antigène
Voir toutes CDKN1C AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Fonction
- CDKN1C Antibody
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogène
- Synthesized peptide derived from the N-terminal region of Human p57.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- CDKN1C (Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C))
-
Autre désignation
- CDKN1C
-
Sujet
- Beckwith Wiedemann syndrome antibody, BWCR antibody, BWS antibody, CDKI antibody, CDKN 1C antibody, CDKN1C antibody, CDN1C_HUMAN antibody, Cyclin dependent kinase inhibitor 1C antibody, Cyclin dependent kinase inhibitor p57 antibody, Cyclin-dependent kinase inhibitor 1C antibody, Cyclin-dependent kinase inhibitor p57 antibody, KIP 2 antibody, KIP2 antibody, p57 antibody, p57 Kip 2 antibody, p57KIP2 antibody, WBS antibody
-
UniProt
- P49918
-
Pathways
- Cycle Cellulaire, Dopaminergic Neurogenesis
Antigène
-